Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001220127 | SCV001392101 | pathogenic | Exostoses, multiple, type 2 | 2023-03-22 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Val68Aspfs*6) in the EXT2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EXT2 are known to be pathogenic (PMID: 10679937, 19810120). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of hereditary multiple exostoses (Invitae). ClinVar contains an entry for this variant (Variation ID: 948798). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV004720095 | SCV005325258 | pathogenic | not provided | 2024-01-03 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge |